Purdue Pharma L.P., headquartered in Stamford, Connecticut is a pharmaceutical company specializing in research on pain prevention. Associated companies also deal with other therapeutic areas such as respiratory disease, oncology, and bacterial infection, and to a growing line of non-prescription products including laxatives, microbicides, antibiotic ointments, and nutraceuticals.

Purdue Pharma has been the target of at least 13 lawsuits in five states due to claims that the company failed to fully disclose the highly addictive properties of its opioid analgesic OxyContin. In 2001, Richard Blumenthal, the Attorney General of Purdue Pharma's home state of Connecticut, urged the company to completely overhaul and reform its marketing and distribution and to devote a specified percentage of its profits to treatment and rehabilitation of OxyContin addiction, resulting from both legitimate and illicit use. The company has since implemented a program to reduce the abuse and diversion of prescription drugs without compromising patient access to proper pain control.

References

• Who We Are, Purdue Pharma.
• Official Statement of Connecticut Attorney General's Office regarding Purdue Pharma and Oxycontin Addiction